HK-2xZFN-mEGFP-Nup107 Cells
USD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The HK-2xZFN-mEGFP-Nup107 cell line is a genetically engineered variant of the Hela Kyoto cell line, derived from human cervical cancer cells. This cell line has been modified using Zinc Finger Nuclease (ZFN) technology to integrate monomeric Enhanced Green Fluorescent Protein (mEGFP) into the Nup107 gene, a crucial component of the nuclear pore complex (NPC). Nup107 plays a key role in nucleocytoplasmic transport, essential for cellular homeostasis and gene regulation. The mEGFP integration enables visualization and tracking of Nup107, facilitating studies on the NPC's dynamics and functions. This fluorescent tagging helps understand Nup107's spatial and temporal distribution and its interactions with other nucleoporins and transport factors. The HK-2xZFN-mEGFP-Nup107 cell line is invaluable for researching cellular transport mechanisms and disease pathophysiology. This cell line provides a robust model for studying the NPC's intricate workings and its health and disease implications, combining the genetic stability and human origin of Hela Kyoto cells with advanced genetic engineering. |
|---|---|
| Organism | Human |
| Tissue | Endocervix |
| Disease | Adenocarcinoma |
Characteristics
| Age | 30 years |
|---|---|
| Gender | Female |
| Ethnicity | African American |
| Morphology | Epithelial-like cells with mosaic stone shape |
| Growth properties | Adherent |
Regulatory Data
| Citation | HK-2xZFN-mEGFP-Nup107 (Cytion catalog number 300676) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_VL12 |
| Depositor | The Ellenberg Lab (EMBL) |
| GMO Status | GMO-S1: This HeLa Kyoto line contains a ZFN-integrated mEGFP fusion at the Nup107 locus enabling nuclear pore complex imaging. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Products | EGFP (Enhanced Green Fluorescent Protein) Nup107 |
|---|
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300676-217 | Certificate of Analysis | 21. Jul. 2025 | 300676 |